基金经理：朱恒红
| 单位净值:0.6111 | 净值增长率:-0.10% | 净值增长率:-0.10% | 累计净值:0.6111 | 截止日期:2024/9/6 | |
|---|---|---|---|---|---|
| 最新估值:-(-) | 涨跌幅:- | 涨跌额:- | |||
| 最新规模:2.99亿元 | 风险等级:高风险 | 申购状态:不可申购 | 赎回状态:可赎回 |
展开全部
- 基本资料
- 投资风格
- 基金财务状况
- 基金评级
南方恒生香港上市生物科技ETF(QDII)(159615)申购赎回 |
||||||
|---|---|---|---|---|---|---|
| 报告期 | 期初总份额(份) | 期末总份额(份) | 期间总申购份额(份) | 期间总赎回份额(份) | 期间净申赎份额(份) | 净申赎比例 |
| 2024/6/30 | 431,055,000 | 490,055,000 | 169,000,000 | 110,000,000 | 59,000,000 | 13.69% |
| 2024/6/30 | 504,055,000 | 490,055,000 | 57,000,000 | 71,000,000 | -14,000,000 | -2.78% |
| 2024/3/31 | 431,055,000 | 504,055,000 | 112,000,000 | 39,000,000 | 73,000,000 | 16.94% |
| 2023/12/31 | 208,055,000 | 431,055,000 | 276,000,000 | 53,000,000 | 223,000,000 | 107.18% |
| 2023/12/31 | 318,055,000 | 431,055,000 | 113,000,000 | 0 | 113,000,000 | 35.53% |
| 2023/9/30 | 275,055,000 | 318,055,000 | 44,000,000 | 1,000,000 | 43,000,000 | 15.63% |
| 2023/6/30 | 208,055,000 | 275,055,000 | 119,000,000 | 52,000,000 | 67,000,000 | 32.2% |
| 2023/6/30 | 198,055,000 | 275,055,000 | 77,000,000 | 0 | 77,000,000 | 38.88% |
| 2023/3/31 | 208,055,000 | 198,055,000 | 42,000,000 | 52,000,000 | -10,000,000 | -4.81% |
| 2022/12/31 | 1,109,050,000 | 208,055,000 | 53,000,000 | 954,000,000 | -901,000,000 | -81.24% |
| 2022/12/31 | 395,055,000 | 208,055,000 | 5,000,000 | 192,000,000 | -187,000,000 | -47.34% |
| 2022/9/30 | 909,055,000 | 395,055,000 | 30,000,000 | 544,000,000 | -514,000,000 | -56.54% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。